Table 4.
Outcome according to stroke aetiology in propensity-matched analysis (matched according to demographic data, baseline characteristics and therapy details).
| Cardioembolic
group n = 61 |
Large-artery atherosclerosis group*
n = 61 |
p-value† | Odds ratio† (95% CI) | p-value shift analysis | |
|---|---|---|---|---|---|
| mRS at 3 months | 0.570‡ | ||||
| 0–1 | 16 (26.2%) | 11 (18%) | 0.278 | 1.62 (0.68–3.85) | |
| 0–2 | 32 (52.5%) | 28 (45.9%) | 0.469 | 1.30 (0.64–2.65) | |
| 0–5 (survival) | 47 (77%) | 48 (78.7%) | 0.827 | 0.91 (0.39–2.14) | |
| Median, range | 2, 0–6 | 3, 0–6 | 0.463 | ||
| NIHSS score at discharge from acute care | |||||
| Median change, range | −5, −21 to 34 | −5, −21 to 37 | 0.925 | ||
| Median, range | 4, 0–42 | 7, 0–42 | 0.142 | ||
| Final in-hospital infarct volume | 0.535 | 0.336‡ | |||
| <30 ml | 30 (50%) | 24 (40%) | |||
| 30–90 ml | 21 (35%) | 26 (43.3%) | |||
| >90 ml | 9 (15%) | 10 (16.7%) | |||
| Successful reperfusion (mTICI 2b/3) | 46 (75.4%) | 40 (65.6%) | 0.235 | 1.61 (0.73–3.54) | 0.200‡ |
| Updated Charlson Comorbidity Index | 0.215‡ | ||||
| Median, range | 2, 0–12 | 4, 0–9 | 0.393 | ||
| Subitem heart failure | 20 (32.8%) | 15 (24.6%) | 0.318 | 1.50 (0.68–3.30) | |
| Symptomatic intracranial haemorrhage | 5 (8.2%) | 4 (6.6%) | 0.730 | 1.27 (0.33–4.99) | NA |
Values are presented as number (%). Percentages indicate available data. Missing data were considered as missing, as they were incidentally missing.
*
Denominator.
†
Values compare both groups.
‡
Shift over the whole spectrum of the score.
CI, confidence interval; mRS, modified Rankin scale; mTICI, modified thrombolysis in cerebral infarction; NIHSS, National Institutes of Health Stroke Scale; NA, not applicable.